Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...

Source: Faith Leonard and Gretchen Jacobson, “What Does the Decline in Medicare Part D Plan Availability Mean for Beneficiaries?,” To the Point (blog), Commonwealth Fund, Dec. 17, 2025.

Stuck in a costly Medicare Part D plan? High drug prices and coverage issues aren't the end. Learn steps you can take now to ...

The current state of the Medicare Part D market is a mixed bag, with premiums declining but many payers scaling back options, according to a new analysis from KFF. The report noted that the Centers ...

The Inflation Reduction of Act of 2022 included improvements to Medicare Part D, and some have already been enacted—$35 insulin, no more member cost share in the catastrophic phase of coverage, and ...

Medicare Part D covers prescription drugs for Medicare and can be purchased from a private insurance company. The average monthly premium for Part D is $46.50 in 2025, and the out-of-pocket maximum is ...

The national average bid amount for Part D plans will increase from $64.28 in 2024 to $179.45 in 2025, according to information released Monday by the Centers for Medicare and Medicaid Services. The ...

AARP offers Medicare Part D plans through UnitedHealthcare. Individuals do not have to be AARP members to enroll in these plans. UnitedHealthcare partners with AARP to offer Medicare-eligible ...

Forbes contributors publish independent expert analyses and insights. Bob Carlson researches all facets of retirement finances. The final numbers aren’t in yet, but it looks like premiums for Medicare ...

Forbes contributors publish independent expert analyses and insights. Diane Omdahl is a Medicare expert who keeps her readers in the know. “FACT SHEET: Seniors Across the Country Are Saving Millions ...

Medicare Part D drug prices have increased by an average of 226% since market entry. These 25 drugs are responsible for $80.9 billion in total Part D spending in 2021. The new report (PDF) from AARP’s ...